Experimental drugs bypass Russians

Foreign pharmaceutical companies suspended clinical trials to Russian Federation In the first half of the year 2022 to Russian Federation, according to profile association, a half of clinical trials of medicines was not begun or suspended, carried out for the purpose of their subsequent state registration For the first six months of this year to Russian Federation were not carried out or nearly 50% the planned clinical trials of the innovative drugs which purpose is the subsequent state registration medicines were suspended before. Such data contain in the bulletin...